Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective. (2023). Biomolecules and Biomedicine, 23(2), 351. https://doi.org/10.17305/bjbms.2022.8354